Variants in MTNR1B influence fasting glucose levels

被引：566

作者：

Prokopenko, Inga ^{[2
,3
]}

Langenberg, Claudia ^{[4
]}

Florez, Jose C. ^{[5
,6
,7
,8
]}

Saxena, Richa ^{[5
,9
]}

Soranzo, Nicole ^{[10
,11
]}

Thorleifsson, Gudmar ^{[12
]}

Loos, Ruth J. F. ^{[4
]}

Manning, Alisa K. ^{[13
]}

Jackson, Anne U. ^{[1
]}

Aulchenko, Yurii ^{[14
]}

Potter, Simon C. ^{[10
]}

Erdos, Michael R. ^{[15
]}

Sanna, Serena ^{[16
]}

Hottenga, Jouke-Jan ^{[17
]}

Wheeler, Eleanor ^{[10
]}

Kaakinen, Marika ^{[18
]}

Lyssenko, Valeriya ^{[19
]}

Chen, Wei-Min ^{[20
,21
]}

Ahmadi, Kourosh ^{[11
]}

Beckmann, Jacques S. ^{[22
,23
]}

Bergman, Richard N. ^{[24
]}

Bochud, Murielle ^{[25
]}

Bonnycastle, Lori L. ^{[15
]}

Buchanan, Thomas A. ^{[26
]}

Cao, Antonio ^{[16
]}

Cervino, Alessandra ^{[11
]}

Coin, Lachlan ^{[27
]}

Collins, Francis S. ^{[15
]}

Crisponi, Laura ^{[16
]}

De Geus, Eco J. C. ^{[17
]}

Dehghan, Abbas ^{[14
]}

Deloukas, Panos ^{[10
]}

Doney, Alex S. F. ^{[28
]}

Elliott, Paul ^{[27
]}

Freimer, Nelson ^{[29
]}

Gateva, Vesela ^{[1
]}

Herder, Christian ^{[30
]}

Hofman, Albert ^{[14
]}

Hughes, Thomas E. ^{[31
]}

Hunt, Sarah ^{[10
]}

Illig, Thomas ^{[32
]}

Inouye, Michael ^{[10
]}

Isomaa, Bo ^{[33
]}

Johnson, Toby ^{[22
,30
]}

Kong, Augustine ^{[12
]}

Krestyaninova, Maria ^{[34
]}

Kuusisto, Johanna ^{[35
,36
]}

Laakso, Markku ^{[35
,36
]}

Lim, Noha ^{[37
]}

Lindblad, Ulf ^{[38
,39
]}

机构：

[1] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA

[2] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England

[3] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England

[4] Addenbrookes Hosp, Epidemiol Unit, MRC, Cambridge CB2 0QQ, England

[5] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA

[6] Harvard Univ, Sch Med, Dept Med, Boston, MA USA

[7] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA

[8] Massachusetts Gen Hosp, Dept Med, Diabet Unit, Boston, MA 02114 USA

[9] Massachusetts Gen Hosp, Dept Mol Biol, Ctr Human Genet Res, Boston, MA 02114 USA

[10] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England

[11] Kings Coll London, Twin Res & Genet Epidemiol Dept, London SE1 7EH, England

[12] deCODE Genet, IS-101 Reykjavik, Iceland

[13] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA

[14] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands

[15] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA

[16] Cittadella Univ Monserrato, CNR, INN, I-09042 Cagliari, Italy

[17] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands

[18] Univ Oulu, Inst Hlth Sci & Biocenter Oulu, Oulu 90014, Finland

[19] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden

[20] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA 22908 USA

[21] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA

[22] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland

[23] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland

[24] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA

[25] CHU Vaudois, Univ Inst Social & Prevent Med, CH-1011 Lausanne, Switzerland

[26] Univ So Calif, Keck Sch Med, Div Endocrinol, Dept Med, Los Angeles, CA 90033 USA

[27] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England

[28] Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland

[29] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA

[30] Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany

[31] Novartis Inst BioMed Res, Diabet & Metab Dis Area, Cambridge, MA 02139 USA

[32] Helmholtz Zentrum Muenchen, Natl Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany

[33] Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland

[34] European Bioinformat Inst, EMBL, Hinxton, England

[35] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland

[36] Kuopio Univ Hosp, SF-70210 Kuopio, Finland

[37] Glaxo SmithKline, Med Genet Clin Pharmacol & Discovery Med, King Of Prussia, PA 19406 USA

[38] Skaraborg Inst, Skovde, Sweden

[39] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden

[40] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA

[41] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Populat Pharmacogenet Grp, Dundee DD1 9SY, Scotland

[42] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland

[43] Natl Publ Hlth Inst KLT, Dept Child & Adolescent Hlth, Oulu 90101, Finland

[44] Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany

[45] Savitaipale Hlth Ctr, Savitaipale 54800, Finland

[46] Ist Patol Endocrina & Metabol, Unita Operat Geriatria, Rome, Italy

[47] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands

[48] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 GZ Groningen, Netherlands

[49] Univ Helsinki, Helsinki Univ Hosp, Dept Med, FIN-00014 Helsinki, Finland

[50] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, SF-00300 Helsinki, Finland

来源：

NATURE GENETICS | 2009年 / 41卷 / 01期

基金：

英国医学研究理事会; 英国惠康基金;

关键词：

GENOME-WIDE ASSOCIATION; BETA-CELL FUNCTION; GENE-EXPRESSION; PLASMA-GLUCOSE; RISK LOCI; MELATONIN; TRIGLYCERIDE; REPLICATION; HAPLOTYPE; IMPACT;

D O I：

10.1038/ng.290

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

To identify previously unknown genetic loci associated with fasting glucose concentrations, we examined the leading association signals in ten genome-wide association scans involving a total of 36,610 individuals of European descent. Variants in the gene encoding melatonin receptor 1B (MTNR1B) were consistently associated with fasting glucose across all ten studies. The strongest signal was observed at rs10830963, where each G allele (frequency 0.30 in HapMap CEU) was associated with an increase of 0.07 (95% CI = 0.06-0.08) mmol/l in fasting glucose levels (P = 3.2 x 10(-50)) and reduced beta-cell function as measured by homeostasis model assessment (HOMA-B, P = 1.1 x 10(-15)). The same allele was associated with an increased risk of type 2 diabetes (odds ratio = 1.09 (1.05-1.12), per G allele P = 3.3 x 10(-7)) in a meta-analysis of 13 case-control studies totaling 18,236 cases and 64,453 controls. Our analyses also confirm previous associations of fasting glucose with variants at the G6PC2 (rs560887, P = 1.1 x 10(-57)) and GCK (rs4607517, P = 1.0 x 10(-25)) loci.

引用

页码：77 / 81

页数：5

共 50 条

[31] MTNR1B genotype influences glycemic response to carbohydrates
Simon, Annika
DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (02) : 109 - 109
[32] Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes
Amélie Bonnefond
Nathalie Clément
Katherine Fawcett
Loïc Yengo
Emmanuel Vaillant
Jean-Luc Guillaume
Aurélie Dechaume
Felicity Payne
Ronan Roussel
Sébastien Czernichow
Serge Hercberg
Samy Hadjadj
Beverley Balkau
Michel Marre
Olivier Lantieri
Claudia Langenberg
Nabila Bouatia-Naji
Guillaume Charpentier
Martine Vaxillaire
Ghislain Rocheleau
Nicholas J Wareham
Robert Sladek
Mark I McCarthy
Christian Dina
Inês Barroso
Ralf Jockers
Philippe Froguel
Nature Genetics, 2012, 44 : 297 - 301
[33] Relationship between MTNR1B (melatonin receptor 1B gene) polymorphism rs10830963 and glucose levels in overweight children and adolescents
Reinehr, Thomas
Scherag, Andre
Wang, Hai-Jun
Roth, Christian L.
Kleber, Michaela
Scherag, Susann
Boes, Tanja
Vogel, Carla
Hebebrand, Johannes
Hinney, Anke
PEDIATRIC DIABETES, 2011, 12 (04) : 435 - 441
[34] Association of MTNR1B polymorphisms with glucose tolerance after one night of simulated night shift
Higuchi, Shigekazu
Sato, Akito
Ohashi, Michihiro
Eto, Taisuke
Nishimura, Takayuki
Yasukochi, Yoshiki
Nakayama, Kazuhiro
Oota, Hiroki
JOURNAL OF SLEEP RESEARCH, 2024, 33
[35] Effects of MTNR1B genetic variants on the risk of type 2 diabetes mellitus: A meta-analysis
Shen, Ling-long
Jin, Yin
MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (05):
[36] Effects of MTNR1B Genetic Variants on Individual Susceptibility to Gestational Diabetes Mellitus: A Meta-Analysis
Jia, Guangliang
Gao, Yanxiang
Li, Chunzhi
Zhang, Yanqin
AMERICAN JOURNAL OF PERINATOLOGY, 2020, 37 (06) : 607 - 612
[37] MTNR1B G24E Variant Associates With BMI and Fasting Plasma Glucose in the General Population in Studies of 22,142 Europeans
Andersson, Ehm A.
Holst, Birgitte
Sparso, Thomas
Grarup, Niels
Banasik, Karina
Holmkvist, Johan
Jorgensen, Torben
Borch-Johnsen, Knut
Egerod, Kristoffer L.
Lauritzen, Torsten
Sorensen, Thorkild I. A.
Bonnefond, Amelie
Meyre, David
Froguel, Philippe
Schwartz, Thue W.
Pedersen, Oluf
Hansen, Torben
DIABETES, 2010, 59 (06) : 1539 - 1548
[38] Comments on "Effects of MTNR1B Genetic Variants on Individual Susceptibility toGestationalDiabetes Mellitus: A Meta-Analysis"
Gholami, Morteza
Amoli, Mahsa M.
AMERICAN JOURNAL OF PERINATOLOGY, 2021, 38 (03) : 310 - 312
[39] Large Scale Meta-Analyses of Fasting Plasma Glucose Raising Variants in GCK, GCKR, MTNR1B and G6PC2 and Their Impacts on Type 2 Diabetes Mellitus Risk
Wang, Haoran
Liu, Lei
Zhao, Jinzhao
Cui, Guanglin
Chen, Chen
Ding, Hu
Wang, Dao Wen
PLOS ONE, 2013, 8 (06):
[40] The relationship between the MTNR1B polymorphism and myocardial infarction susceptibility
Skrlec, Ivana
Dzijan, Snjezana
Talapko, Jasminka
Cesar, Vera
EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 147 - 147

← 1 2 3 4 5 →